Dr. Floudas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Center Drive
Rm 13N240
Bethesda, MD 20892
Education & Training
Maimonides Medical CenterResidency, Internal Medicine, 2013 - 2016
University of Crete School of Health SciencesClass of 2000
Certifications & Licensure
MD State Medical License 2016 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 12 citationsEfficacy and safety of PARP inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of clinical trials.Giovanni Maria Iannantuono, Elias Chandran, Charalampos S Floudas, Hyoyoung Choo-Wosoba, Gisela Butera
Cancer Treatment Reviews. 2023-11-01 - 20 citationsPhase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer.Peter Joseph DeMaria, Katherine Lee-Wisdom, Renee N. Donahue, Ravi A. Madan, Fatima Karzai
Journal for Immunotherapy of Cancer. 2021-09-01 - 67 citationsTremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract Cancer.Changqing Xie, Austin G. Duffy, Donna Mabry-Hrones, Bradford J. Wood, Elliot Levy
Hepatology. 2019-05-01
Press Mentions
Study in India Could Make Immunotherapy More Affordable WorldwideNovember 22nd, 2022- Precigen Reports Second Quarter and First Half 2021 Financial ResultsAugust 9th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
